Alexandra Kropotova

Alexandra Kropotova

Chief Tech/Sci/R&D Officer at SAB BIOTHERAPEUTICS, INC.

Net worth: 155 866 $ as of 2026-05-30

54 year
Health Technology
Consumer Services

Profile

Alexandra Kropotova is currently an Independent Director at iBio, Inc. since 2020 and Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. since 2022.
Formerly, Dr. Kropotova worked at Pfizer Inc. from 2002 to 2007 as Director & Head-Global Clinical Respiratory, at Sanofi from 2007 to 2016 as Vice President-Strategy & Head-Strategic Planning, and at Teva Pharmaceuticals, Inc. from 2016 to 2022 as VP-Global Specialty Research & Development.
Education includes an MBA from Ohio University Graduate College and a doctorate from Pacific State Medical University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-23 43,296 ( 0.06% ) 155 866 $ 2026-05-30
2025-11-19 0 ( -.--% ) - $ 2026-05-30

Alexandra Kropotova active positions

CompaniesPositionStart
IBIO, INC. Director/Board Member 2020-10-13
SAB BIOTHERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2022-06-05

Former positions of Alexandra Kropotova

CompaniesPositionEnd
Corporate Officer/Principal 2022-05-31
SANOFI Corporate Officer/Principal 2015-12-31
PFIZER INC. Director/Board Member 2006-12-31
See the detail of Alexandra Kropotova's experience

Training of Alexandra Kropotova

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Alexandra Kropotova
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!